Sionna Therapeutics SION Income Statement (2023-2026)

NASDAQ SION
$3.70 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Sionna Therapeutics Quarterly Income Statement

Periods 12 quarters
Latest Sep 2026

Sionna Therapeutics reported net income of -$32.69M for the quarter ended Sep 2026. This income statement covers 12 quarters of results from Dec 2023 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating items
Research & DevelopmentR&D 10.22M8.23M24.58M14.25M13.67M15.38M16.04M15.17M18.96M21.86M22.03M
Selling, General & AdministrativeSG&A 2.93M3.06M3.40M3.88M5.99M6.52M7.76M8.44M10.64M10.61M12.79M
Other Operating ExpensesOther Opex 0.17M0.07M0.00M-0.01M
Operating ExpensesOpex 13.15M11.29M27.98M18.13M19.66M21.91M23.81M23.61M29.60M32.47M34.82M
Operating IncomeOp. Inc -13.15M-11.29M-27.98M-18.13M-19.66M-21.91M-23.81M-23.61M-29.60M-32.47M-34.82M
Non-operating items
Gains (Losses) on Sale of Assets & InvestmentsGains on Sales -0.01M-0.15M0.93M-0.41M-0.07M-0.12M0.24M0.12M-0.62M-0.36M-0.28M
Interest & Investment IncomeInt & Inv Inc 1.13M2.57M2.35M2.12M3.00M3.67M3.46M3.17M2.82M2.59M2.41M
Other Non Operating IncomeOther Non Op Inc. 0.17M0.17M0.19M0.17M0.18M0.17M0.07M
Non Operating IncomeNon Op. Inc. 1.30M2.74M2.54M2.29M3.18M3.84M3.53M3.17M2.82M2.58M2.40M
Net income details
EBIT -13.15M-11.29M-27.98M-18.13M-19.66M-21.91M-23.81M-23.61M-29.60M-32.47M-34.82M
EBT -12.02M-8.73M-25.63M-16.01M-16.66M-18.24M-20.35M-20.44M-26.78M-29.88M-32.41M
Income After Tax -12.02M-8.73M-25.63M-16.01M-16.66M-18.24M-20.35M-20.44M-26.78M-29.88M-32.41M
Income from Continuing OperationsIncome (Continuing) -12.02M-8.73M-25.63M-16.01M-16.66M-18.24M-20.35M-20.44M-26.78M-29.88M-32.41M
Consolidated Net IncomeConsol Net Inc. -11.86M-8.70M-24.51M-16.25M-16.55M-18.19M-20.04M-20.32M-27.40M-30.25M-32.69M
Income towards Parent CompanyParent Net Inc -11.85M-8.55M-25.44M-15.85M-16.48M-18.07M-20.28M-20.44M-26.78M-29.89M-32.42M
Net Income towards Common StockholdersNet Income -11.85M-8.55M-25.44M-15.85M-16.48M-18.07M-20.28M-20.44M-26.78M-29.89M-32.42M
Additional items
EPS (Basic) -3.84-2.71-5.67-4.11-0.62-0.41-0.46-0.51-0.60-0.66-0.72
EPS (Diluted) -3.84-2.71-5.67-4.11-0.62-0.41-0.46-0.51-0.60-0.66-0.72
Shares Outstanding 2.93M3.08M3.16M4.49M3.86M26.60M44.12M44.26M39.96M44.92M45.15M45.21M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 3.08M3.16M4.49M3.86M26.60M44.12M44.26M39.96M44.92M45.15M45.21M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 3.05M3.10M3.18M4.66M3.86M26.60M44.13M44.46M44.72M45.08M45.16M45.21M
EBITDA -13.06M-12.20M-28.78M-18.72M-20.16M-22.97M-24.54M-23.82M-29.60M-32.43M-34.83M

Sionna Therapeutics Income Statement API

Pull Sionna Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SION&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY